JLE

Hépato-Gastro & Oncologie Digestive

MENU

Efficacité du bézafibrate chez les malades atteints de cholangite biliaire primitive répondant insuffisamment à l’acide ursodésoxycholique Volume 25, numéro 9, Novembre 2018

  • [1] Poupon R.E., Poupon R., Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med. 1994;330:1342-1347. and the UDCA-PBC study group
  • [2] Pariente A. Un nouveau traitement pour la cholangite (ex-cirrhose) biliaire primitive. Hépato-Gastro. 2016;23:910-914.
  • [3] Nakai S., Masaki T., Kurokohchi K., Deguchi A., Nishioka M. Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis : a preliminary study. Am J Gastroenterol. 2000;95:326-327.
  • [4] Reig A., Sesé P., Parés A. Effects of bezafibrate on outcome on outcome and pruritus in primary biliary cholangitis with suboptimal ursodeoxycholic acid response. Am J Gastroeneterol. 2018;113:49-55.
  • [5] Mathivat A., Cottet J. Clinical trials on the hypocholesterolemia-producing effect of 2-phenylbutyric acid. Bull Mem Soc Hop Paris. 1953;69:1030-1048.